Mrs. Rosenqvist is a Board member of CAMP ATMP Sweden and Nordic Cell Therapy lead at Janssen (Johnson&Johnson). She has experience of leading pharma into a new way of working in Europe – new ways of collaborate in partnership with diverse stakeholders in the ”ecosystem” with the healthcare system, academy, universities authorities and the life science sector. She unleashes the power in people by having an inclusive and inspiring leadership style.
Chief Medical Officer and Head of International Business Development
Eurofins LifeCodexx, Germany